SRX Global's Board of Directors has authorized a share repurchase program allowing the company to buy back up to 10 million shares of its common stock, representing up to 50% of its shares outstanding. The company has allocated up to $20 million for the program, which runs until July 9, 2027. CEO Kent Cunningham stated that with no debt, a strong cash position, and the current market value of the shares, the repurchase program is a compelling use of capital and reflects the board's confidence in SRX's long-term strategy. Repurchases may be conducted in open market or private transactions, funded by cash on hand, and are subject to market conditions and other factors.
SRx Health Solutions Inc.Board authorized a share repurchase of up to 10 million shares, signaling confidence and returning capital to shareholders.